Journal ArticleDOI
Electroconvulsive therapy in adolescents with intellectual disability and severe self-injurious behavior and aggression: a retrospective study
TLDR
ECT appears beneficial in severe, treatment-resistant SHBA in adolescents with intellectual disability with resistance to behavioral interventions and pharmacotherapy from 2007 to 2011.Abstract:
Efficacious intervention for severe, treatment-refractory self-injurious behavior and aggression (SIB/AGG) in children and adolescents with intellectual disability and concomitant psychiatric disorders remains a complex and urgent issue. The aim of this study is to assess the efficacy of electroconvulsive therapy (ECT) on severe and treatment-resistant SIB/AGG in young people with intellectual disability and current psychiatric disorder. We reviewed the charts of all patients (N = 4) who received ECT in the context of SIB/AGG with resistance to behavioral interventions, milieu therapy and pharmacotherapy from 2007 to 2011. We scored the daily rate of SIB/AGG per patient for each hospital day. Inter rater reliability was good (intraclass correlations = 0.91). We used a mixed generalized linear model to assess whether the following explanatory variables (time, ECT) influenced the course of SIB/AGG over time, the dependant variable. The sample included two girls and two boys. The mean age at admission was 13.8 years old [range 12-14]. The patients had on average 19 ECT sessions [range 16-26] and one patient received maintenance ECT. There was no effect of time before and after ECT start. ECT was associated with a significant decrease in SIB/AGG scores (p < 0.001): mean aggression score post-ECT was half the pre-ECT value. ECT appears beneficial in severe, treatment-resistant SHBA in adolescents with intellectual disability.read more
Citations
More filters
Journal ArticleDOI
The co-occurrence of autism and attention deficit hyperactivity disorder in children - what do we know?
TL;DR: The present review will examine the frequency and implications of this clinical co-occurrence in children, with an emphasis on the available data regarding pre-school age, in light of the new DSM-V criteria, allowing for a dual diagnosis.
NMDA receptor dysfunction in autism spectrum disorders
TL;DR: It is suggested that deviation of NMDAR function in either direction contributes to the development of ASDs, and that correcting NMDar dysfunction has therapeutic potential for ASDs.
Therapies for Children With Autism Spectrum Disorder: Behavioral Interventions Update
Amy S. Weitlauf,Melissa L McPheeters,Brittany Peters,Nila A Sathe,Rebekah Travis,Rachel Aiello,Edwin Williamson,Jeremy Veenstra-VanderWeele,Shanthi Krishnaswami,Rebecca N Jerome,Zachary Warren +10 more
TL;DR: A prior systematic review of interventions for children (0-12 years) with autism spectrum disorder (ASD) focusing on recent studies of behavioral interventions was published in 2013.
Journal ArticleDOI
The neurochemistry of autism
Rosa Marotta,Maria Cristina Risoleo,Giovanni Messina,Lucia Parisi,Marco Carotenuto,Luigi Vetri,Michele Roccella +6 more
TL;DR: This review delineates the state-of-the-art main research findings about the neurochemical alterations in autism etiology, and focuses on gamma aminobutyric acid and glutamate, serotonin, dopamine, N-acetyl aspartate, oxytocin and arginine-vasopressin, melatonin, vitamin D, orexin, endogenous opioids, and acetylcholine.
Journal ArticleDOI
NMDA receptor dysfunction in autism spectrum disorders
TL;DR: In this paper, the authors found that deviation of NMDAR function in either direction contributes to the development of ASD, and that correcting this deficiency rescues ASD-like behaviors.
References
More filters
Journal ArticleDOI
Meta-Analysis: A Constantly Evolving Research Integration Tool
TL;DR: The four articles in this special section onMeta-analysis illustrate some of the complexities entailed in meta-analysis methods and contributes both to advancing this methodology and to the increasing complexities that can befuddle researchers.
Journal ArticleDOI
Risperidone in Children with Autism and Serious Behavioral Problems
James T. McCracken,James J. McGough,Bhavik Shah,Pegeen Cronin,Daniel Hong,Michael G. Aman,L. Eugene Arnold,Ronald L. Lindsay,Patricia L. Nash,Jill A. Hollway,Christopher J. McDougle,David J. Posey,Naomi B. Swiezy,Arlene E. Kohn,Lawrence Scahill,Andrés Martin,Kathleen Koenig,Fred R. Volkmar,Deirdre H. Carroll,Allison Lancor,Allison Lancor,Elaine Tierney,Jaswinder K. Ghuman,N. González,Marco A. Grados,Benedetto Vitiello,Louise Ritz,Mark Davies,James Robinson,Donald J. McMahon +29 more
TL;DR: Risperidone was effective and well tolerated for the treatment of tantrums, aggression, or self-injurious behavior in children with autistic disorder and the benefit was maintained at six months.
Journal ArticleDOI
Catatonia. I. Rating scale and standardized examination.
TL;DR: It is concluded that catatonia is a distinct, moderately prevalent neuropsychiatric syndrome and the rating scale and screening instrument are reliable and valid.